The clinicopathological findings in our patient share multiple similarities with CMMRD syndrome, such as presentation in the first decade of life with T-LBL along with high-grade CNS glioma, with tumor cells showing loss of PMS2 expression. This evidence concerns the gene PMS2 and neoplasm.